Positive Media Coverage Likely to Affect Alere (ALR) Stock Price

Media coverage about Alere (NYSE:ALR) has trended positive recently, according to AlphaOne. AlphaOne, a service of Accern, identifies positive and negative press coverage by reviewing more than 20 million blog and news sources. AlphaOne ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Alere earned a daily sentiment score of 0.39 on AlphaOne’s scale. AlphaOne also assigned media stories about the medical research company an impact score of 77 out of 100, meaning that recent press coverage is likely to have an effect on the stock’s share price in the near term.

These are some of the media stories that may have impacted Alpha One Sentiment’s rankings:

Insider Buying and Selling by Quarter for Alere (NYSE:ALR)

A number of analysts recently issued reports on the company. Canaccord Genuity lowered Alere from a “buy” rating to a “hold” rating and set a $51.00 price target for the company. in a report on Tuesday, June 6th. Jefferies Group LLC reiterated a “hold” rating and issued a $51.00 price target on shares of Alere in a report on Thursday, June 1st. BTIG Research reiterated a “hold” rating on shares of Alere in a report on Wednesday, May 24th. Craig Hallum lowered Alere from a “buy” rating to a “hold” rating in a report on Monday, May 15th. Finally, Zacks Investment Research lowered Alere from a “hold” rating to a “strong sell” rating in a report on Wednesday, April 19th. One analyst has rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $49.60.

Alere (ALR) traded up 0.04% during mid-day trading on Friday, reaching $50.20. The company’s stock had a trading volume of 990,147 shares. The company’s 50-day moving average price is $48.94 and its 200 day moving average price is $42.38. The firm’s market capitalization is $4.39 billion. Alere has a 52 week low of $31.47 and a 52 week high of $50.28.

WARNING: This article was first published by Markets Daily and is the property of of Markets Daily. If you are accessing this article on another website, it was illegally copied and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be viewed at https://www.themarketsdaily.com/2017/06/16/alere-alr-earning-positive-press-coverage-report-shows-updated-updated.html.

Alere Company Profile

Alere Inc is a provider of health information through diagnostic tests. The Company’s segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus.

Receive News & Ratings for Alere Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alere Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply